GB202018901D0 - New pharmaceutical composition - Google Patents
New pharmaceutical compositionInfo
- Publication number
- GB202018901D0 GB202018901D0 GBGB2018901.5A GB202018901A GB202018901D0 GB 202018901 D0 GB202018901 D0 GB 202018901D0 GB 202018901 A GB202018901 A GB 202018901A GB 202018901 D0 GB202018901 D0 GB 202018901D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- new pharmaceutical
- new
- composition
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2018901.5A GB202018901D0 (en) | 2020-12-01 | 2020-12-01 | New pharmaceutical composition |
RS20221016A RS63725B1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
ES21728101T ES2929818T3 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug administration |
BR112022023307A BR112022023307A2 (en) | 2020-05-18 | 2021-05-18 | PHARMACEUTICAL COMPOSITION FOR DELIVERY OF DRUGS |
HUE21728101A HUE060573T2 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
PT217281013T PT3962455T (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
SI202130007T SI3962455T1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
PE2022002543A PE20230382A1 (en) | 2020-05-18 | 2021-05-18 | NEW PHARMACEUTICAL COMPOSITION FOR DRUG ADMINISTRATION |
CN202180036365.8A CN115666513A (en) | 2020-05-18 | 2021-05-18 | Novel pharmaceutical compositions for drug delivery |
DK21728101.3T DK3962455T3 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
CA3178769A CA3178769A1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
EP21728101.3A EP3962455B1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
EP22191078.9A EP4154866A1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
AU2021276611A AU2021276611A1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
HRP20221361TT HRP20221361T1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
MX2022014216A MX2022014216A (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery. |
MDE20220282T MD3962455T2 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
JP2022570692A JP2023526098A (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical compositions for drug delivery |
PL21728101.3T PL3962455T3 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
KR1020227040261A KR20230012502A (en) | 2020-05-18 | 2021-05-18 | Novel pharmaceutical compositions for drug delivery |
LTEPPCT/GB2021/051191T LT3962455T (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
IL297658A IL297658A (en) | 2020-05-18 | 2021-05-18 | Pharmaceutical composition for drug delivery |
PCT/GB2021/051191 WO2021234366A1 (en) | 2020-05-18 | 2021-05-18 | New pharmaceutical composition for drug delivery |
US17/540,929 US11737980B2 (en) | 2020-05-18 | 2021-12-02 | Pharmaceutical composition for drug delivery |
CONC2022/0015183A CO2022015183A2 (en) | 2020-05-18 | 2022-10-25 | New pharmaceutical composition for drug administration |
CL2022002979A CL2022002979A1 (en) | 2020-05-18 | 2022-10-26 | New pharmaceutical composition for drug administration |
US18/345,770 US20240024244A1 (en) | 2020-05-18 | 2023-06-30 | New pharmaceutical composition for drug delivery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2018901.5A GB202018901D0 (en) | 2020-12-01 | 2020-12-01 | New pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202018901D0 true GB202018901D0 (en) | 2021-01-13 |
Family
ID=74099900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2018901.5A Ceased GB202018901D0 (en) | 2020-05-18 | 2020-12-01 | New pharmaceutical composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202018901D0 (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702362A (en) | 1995-05-26 | 1997-12-30 | Bayer Aktiengesellschaft | Nasal applicator |
US6398074B1 (en) | 1998-03-10 | 2002-06-04 | Valois S.A. | Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir |
US20050001411A1 (en) | 2001-09-06 | 2005-01-06 | Christian Theiss | Method for the determination of parameters of a seat passenger |
US6938798B2 (en) | 2000-12-08 | 2005-09-06 | Tebro S.A. | Fluid or powdery product dispensing device |
US7722566B2 (en) | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
WO2010142696A1 (en) | 2009-06-11 | 2010-12-16 | Charité - Universitätsmedizin Berlin | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
US20110045088A1 (en) | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
WO2014004400A2 (en) | 2012-06-28 | 2014-01-03 | The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Nasal dry powder delivery system for vaccines and other treatment agents |
US9724713B2 (en) | 2013-07-05 | 2017-08-08 | Aptar France Sas | Fluid or powdery product dispensing device |
US20180092839A1 (en) | 2016-10-03 | 2018-04-05 | Lance L. Gooberman | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders |
WO2019038756A1 (en) | 2017-08-20 | 2019-02-28 | Solubest Ltd. | Dry powder compositions for intranasal delivery |
-
2020
- 2020-12-01 GB GBGB2018901.5A patent/GB202018901D0/en not_active Ceased
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702362A (en) | 1995-05-26 | 1997-12-30 | Bayer Aktiengesellschaft | Nasal applicator |
US6398074B1 (en) | 1998-03-10 | 2002-06-04 | Valois S.A. | Reservoir, reservoir filling method and device for dispensing fluid contained in the reservoir |
US6938798B2 (en) | 2000-12-08 | 2005-09-06 | Tebro S.A. | Fluid or powdery product dispensing device |
US20050001411A1 (en) | 2001-09-06 | 2005-01-06 | Christian Theiss | Method for the determination of parameters of a seat passenger |
US7722566B2 (en) | 2003-10-09 | 2010-05-25 | Shin Nippon Biomedical Laboratories, Ltd. | Device to deliver a powdery medicine into nasal cavity |
WO2010142696A1 (en) | 2009-06-11 | 2010-12-16 | Charité - Universitätsmedizin Berlin | Use of opioid receptor antagonists for acute treatment of paraphilic arousal states |
US20110045088A1 (en) | 2009-07-31 | 2011-02-24 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
WO2014004400A2 (en) | 2012-06-28 | 2014-01-03 | The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services | Nasal dry powder delivery system for vaccines and other treatment agents |
US9724713B2 (en) | 2013-07-05 | 2017-08-08 | Aptar France Sas | Fluid or powdery product dispensing device |
US20180092839A1 (en) | 2016-10-03 | 2018-04-05 | Lance L. Gooberman | Medicated spray for treatment of substance abuse, overdose, addiction and impulse control disorders |
WO2019038756A1 (en) | 2017-08-20 | 2019-02-28 | Solubest Ltd. | Dry powder compositions for intranasal delivery |
Non-Patent Citations (12)
Title |
---|
"Aulton's Pharmaceutics: The Design and Manufacture of Medicines", 2013, ELSEVIER |
"Pharmaceutical Dosage Forms: Tablets", vol. 1, 2008, CRC PRESS |
"Remington: The Science and Practice of Pharmacy", 2006, UNIVERSITY OF THE SCIENCES IN PHILADELPHIA |
"The HLB System: A Time-Saving Guide to Emulsifier Selection", 1976, ICI AMERICAS INC, pages: 20 - 21 |
BERTAN ET AL., EUR. J. PHARM. SCI., vol. 27, 2006, pages 62 |
GANDHI, ADVANCED DRUG DELIVERY REVIEWS, vol. 43, 1994, pages 67 |
J. DRUG DELIVERY, 2018, pages 1 - 19 |
LACHMAN ET AL.: "The Theory and Practice of Industrial Pharmacy", 1986, LEA & FEBIGER |
MARTINDALE: "The Complete Drug Reference", 2014, PHARMACEUTICAL PRESS |
RUSSO ET AL., J. PHARM. SCI., vol. 95, 2006, pages 2253 |
SHOJAEL, J. PHARM. PHARMACEUTICAL SCI., vol. 15, 1998, pages 19 |
VENGEROVICH ET AL., BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 163, 2017, pages 737 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202019241D0 (en) | Pharmaceutical composition | |
IL304290A (en) | Pharmaceutical composition | |
GB201911517D0 (en) | Pharmaceutical composition | |
FI3908321T3 (en) | Pharmaceutical composition | |
GB202117005D0 (en) | New pharmaceutical composition | |
GB202117007D0 (en) | New pharmaceutical composition | |
GB202117015D0 (en) | New pharmaceutical composition | |
GB202018901D0 (en) | New pharmaceutical composition | |
GB202009905D0 (en) | New pharmaceutical composition | |
GB202007328D0 (en) | New pharmaceutical composition | |
GB202007306D0 (en) | New pharmaceutical composition | |
GB202208464D0 (en) | Pharmaceutical composition | |
GB202109271D0 (en) | Pharmaceutical composition | |
GB202108387D0 (en) | Pharmaceutical composition | |
GB202107518D0 (en) | Pharmaceutical composition | |
GB202105858D0 (en) | Pharmaceutical composition | |
GB202105462D0 (en) | Pharmaceutical composition | |
GB202105047D0 (en) | Pharmaceutical composition | |
GB202105049D0 (en) | Pharmaceutical composition | |
GB202104224D0 (en) | Pharmaceutical composition | |
GB202102095D0 (en) | Pharmaceutical composition | |
GB202102100D0 (en) | Pharmaceutical composition | |
GB202101634D0 (en) | Pharmaceutical composition | |
GB202101640D0 (en) | Pharmaceutical composition | |
GB202101638D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |